• Català
  • Castellano
  • English
  • Cancer Prevention and Control Program
    • Biomarkers
      • Group
      • Research
      • Projects
      • Publications
      • Applications
      • Contact
    • Tobacco
      • Group
      • Research
      • Projects
      • Publications
      • Applications
      • Contact
    • Screening
      • Group
      • Research
      • Projects
      • Publications
      • Contact
  • Education & Teaching
  • Work with us
  • How to arrive

            hubc.png

Home ›

Publications

  • List
  • Filter
  • Author
  • Keyword
  • Title
  • Type  (Asc)
  • Year
Filters: Author is Páez, D  [Clear All Filters]
Journal Article
Marcuello E, Páez D, Paré L, Salazar J, Sebio A, del Rio E, et al. A genotype-directed phase I-IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer. British journal of cancer. 2011;105(1):53-7. Abstract
Páez D, Salazar J, Paré L, Pertriz L, Targarona E, del Rio E, et al. Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes. International journal of radiation oncology, biology, physics. 2011;81(5):1319-27. Abstract
Fernandez-Rozadilla C, Cazier JB, Moreno V, Crous-Bou M, Guinó E, Durán G, et al. Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration. The pharmacogenomics journal. 2012. Abstract
Páez D, Paré L, Altés A, Sancho-Poch FJ, Petriz L, Garriga J, et al. Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil. Journal of cancer research and clinical oncology. 2010;136(11):1681-9. Abstract

© Catalan Institute of Oncology

Syndicate content